Trust Size
$35M
Peak Price
$16.24
Current Price
$3.92
Return
-60.8%
What Happened
TriSalus Life Sciences, Inc. filed its S-1 registration in 2020 and completed its business combination in 2022. The company remains actively traded with 452 SEC filings on record.
TriSalus Life Sciences, Inc. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2022.
SEC records show 452 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2020-12-09
S-1 Registration Filed
2022-02-14
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1826667
Total SEC Filings
452
State of Incorporation
DE
Last Filing Date
2026-03-20
Business Location
New York, NY
Trust/Asset Size
$35M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for TriSalus Life Sciences